Invention Grant
- Patent Title: Prodrug of pyrrolidone derivatives as glucokinase activator
-
Application No.: US18333459Application Date: 2023-06-12
-
Publication No.: US12054477B2Publication Date: 2024-08-06
- Inventor: Fuxing Tang , Jin She , Li Chen , Guanghua Lv , Xiangle Jin
- Applicant: HUA MEDICINE (SHANGHAI) LTD.
- Applicant Address: CN Shanghai
- Assignee: HUA MEDICINE (SHANGHAI) LTD.
- Current Assignee: HUA MEDICINE (SHANGHAI) LTD.
- Current Assignee Address: CN Shanghai
- Agency: Jones Day
- Priority: CN 2111079620.5 2021.09.15 CN 2211093895.9 2022.09.08
- Main IPC: C07D403/12
- IPC: C07D403/12 ; A61P3/10 ; C07D401/14 ; C07D405/14

Abstract:
The present disclosure provides a compound of formula (I), or an isotopically labeled product, an enantiomer, a diastereomer or a pharmaceutically acceptable salt thereof; a pharmaceutical composition comprising a compound of formula (I); and use of a compound of formula (I) or a pharmaceutical composition thereof in the treatment of diabetes mellitus and related symptoms.
Public/Granted literature
- US20230322738A1 PRODRUG OF PYRROLIDONE DERIVATIVES AS GLUCOKINASE ACTIVATOR Public/Granted day:2023-10-12
Information query